Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 7921–7940 of 17,529 recalls

December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Valsartan Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Valsartan and Hydrochlorothiazide Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Valsartan and Hydrochlorothiazide Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Valsartan Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 4, 2018· Mylan Laboratories Limited, (Nashik FDF)

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: GCMP Deviations: FDA analysis confirmed presence of trace

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 30, 2018· VistaPharm, Inc.

Recalled Item: NYSTATIN Oral Suspension

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 30, 2018· Aurobindo Pharma USA Inc.

Recalled Item: Amlodipine and Olmesartan Medoxomil Tablets

The Issue: Discoloration: This product is being recalled due to

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 29, 2018· Advanced Pharma Inc.

Recalled Item: Phenylephrine HCl

The Issue: Labeling: Label Error on Declared Strength: Label incorrectly

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
November 27, 2018· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Aprepitant Capsules

The Issue: Shortfill: Aprepitant capsules 40 mg is being recalled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/160 mg

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 5 mg/320 mg

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine and Valsartan Tablets 10 mg/160 mg

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 27, 2018· Teva Pharmaceuticals USA

Recalled Item: Amlodipine

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 26, 2018· Tris Pharma Inc.

Recalled Item: infants* IBUPROFEN

The Issue: Superpotent Drug: recalled lots may have higher concentration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund